Michallet, A., Letestu, R., Garff-Tavernier, M. L., Campos, L., Ticchionni, M., Dilhuydy, M. S., Morisset, S., rouille, V., Laribi, K., Villemagne, B., Ferrant, E., Tournilhac, O., Molina, L., Tomowiak, C., Guibert, S. D., Piocelle, F. O., Banos, A., Carassou, P., Cartron, G., Fornecker, L., Ysebaert, L., Dartigeas, C., Truchan, M., Vilque, J. P., Aurran, T., Lepretre, S., Khac, F. N., Levy, V., Feugier, P. (2025). A fixed-duration, chemo-sparing approach in CLL: 8-year results of the phase 2 icll-07 filo trial. Blood. https://doi.org/10.1182/blood-2025-3883